Position in BLRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$230
-$47 QoQ
Shares Held
100
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BLRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,716,237,057 across 522 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in BLRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $230 | 100 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $277 | 100 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $22,501 | 5,953 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $7,051 | 1,543 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $6,642 | 2,244 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $16,611 | 79,102 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $106,669 | 197,537 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $39,008 | 68,437 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $326,315 | 291,354 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $374,068 | 238,261 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $319,886 | 175,762 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $417,560 | 260,976 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $228,651 | 256,912 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $149,240 | 252,952 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $244,179 | 262,559 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $322,794 | 252,184 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $464,324 | 271,535 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $530,737 | 260,166 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $660,351 | 240,128 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $637,368 | 226,822 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $1,111,569 | 398,412 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,845,120 | 732,191 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,260,069 | 768,335 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $966,344 | 565,114 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $457,398 | 343,909 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||